MRC1+ macrophages facilitate tumour recurrence following chemotherapy, and tumour biopsy samples from cancer patients who received neoadjuvant therapy had a much larger infiltrate of CD45+CD11b+CD14+ macrophages than those from patients who received only surgery.58, 59. Here, PTPRC is linked to neoplasm.